propafenone has been researched along with Cardiovascular Abnormalities in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Cardiovascular Abnormalities: Congenital, inherited, or acquired anomalies of the CARDIOVASCULAR SYSTEM, including the HEART and BLOOD VESSELS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biffi, A | 1 |
| Pelliccia, A | 1 |
| Verdile, L | 1 |
| Fernando, F | 1 |
| Spataro, A | 1 |
| Caselli, S | 1 |
| Santini, M | 1 |
| Maron, BJ | 1 |
1 other study available for propafenone and Cardiovascular Abnormalities
| Article | Year |
|---|---|
Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Cardiovascular Abnormalities | 2002 |